Wound Care Biologics Market Demand, Leading Companies, Trends and Opportunity to 2023-2028
According to IMARC Group's latest report, titled “Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global wound care biologics market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.
Wound care biologics represent drugs semi-synthesized or extracted from natural sources which are utilized for controlling and healing infections. They mostly include topical agents and biologic skin substitutes, such as human donor tissue-derived products, acellular animal-derived products, biosynthetic products, etc. Wound care biologics products exhibit antimicrobial, antioxidant, and anti-inflammatory attributes that help to restore the natural repair mechanism of wounds through active biological agents. Consequently, they find extensive applications in hospitals, burn centers, and wound clinics, across countries.
Request a PDF Sample of the Report: https://www.imarcgroup.com/wound-care-biologics-market/requestsample
Wound Care Biologics Market Trends:
The growing prevalence of chronic wounds caused by burns, skin cancers, infections, or underlying medical conditions, including diabetes, is primarily driving the market. The escalating demand for treatments that can accelerate wound healing and ensure a speedy recovery is acting as another significant growth-inducing factor. The launch of several favorable initiatives by government bodies across the globe aimed at creating awareness about the advantages of wound care biologics among patients is also positively influencing the global market. In addition to this, the development of cost-effective, next-generation, and high-quality biologics by leading market players and the rising focus on making them more accessible are further stimulating the global wound care biologics market growth. The increasing partnerships among research and healthcare centers to modernize wound care treatments and introduce innovative drugs for healing wounds and the emerging trend of combining traditional wound dressings, which include hydrogels or foams with antimicrobial compounds such as chitin, betaine, silver, or polyhexamethylene biguanide are anticipated to propel the market over the forecasted period.
Competitive Landscape:
The competitive landscape of the wound care biologics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
-
Smith & Nephew
-
Mölnlycke Health Care
-
Integra lifesciences
-
Osiris Therapeutics
-
Avita Medical
-
ConvaTec Group
-
Cytori Therapeutics
-
Mylan
-
Johnson & Johnson
-
Leap Therapeutics
-
Nuo Therapeutics
-
Mallinckrodt
-
Wright Medical
-
Mimedx Group
-
Solsys Medical
Key Market Segmentation:
The report has segmented the global wound care biologics market based on product, wound type, application, end-user and region.
Breakup by Product:
-
Biologic Skin Substitutes
-
Human Donor Tissue-Derived Products
-
Acellular Animal-Derived Products
-
Biosynthetic Products
-
-
Topical Agents
Breakup by Wound Type:
-
Ulcers
-
Diabetic Foot Ulcers
-
Venous Ulcers
-
Pressure Ulcers
-
Others
-
-
Surgical and Traumatic Wounds
-
Burns
Breakup by Application:
-
Acute Wound
-
Chronic Wound
-
Surgical Wound
Breakup by End-User:
-
Hospitals
-
ASCs
-
Burn Centres and Wound Clinics
Breakup by Region:
-
Asia Pacific
-
Europe
-
North America
-
Middle East and Africa
-
Latin America
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=1489&flag=C
Key Highlights of the Report:
-
Market Performance (2017-2022)
-
Market Outlook (2023-2028)
-
Market Trends
-
Market Drivers and Success Factors
-
Impact of COVID-19
-
Value Chain Analysis
-
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian